Equities researchers at StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report issued on Sunday. The firm set a “hold” rating on the biopharmaceutical company’s stock.
Sorrento Therapeutics Price Performance
Shares of NASDAQ SRNE opened at $0.00 on Friday. The business has a 50-day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01. Sorrento Therapeutics has a fifty-two week low of $0.00 and a fifty-two week high of $0.25.
About Sorrento Therapeutics
Recommended Stories
- Five stocks we like better than Sorrento Therapeutics
- How to Invest in Insurance Companies: A Guide
- Ciena Stock Powers the AI Cloud Boom—Don’t Miss Out
- Top Stocks Investing in 5G Technology
- Affirm’s Path to Profitability Elevates with Interest Rate Cuts
- Differences Between Momentum Investing and Long Term Investing
- RPM International Thrives in Rate-Cut Driven Construction Rally
Receive News & Ratings for Sorrento Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sorrento Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.